Aeronid 200 mcg/puff inhaler is indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and paediatric patients aged 6 years and above. It is used to reduce airway inflammation and improve long-term asthma control.

It is also indicated for patients who require oral corticosteroid therapy for asthma. In many such patients, regular use of Aeronid 200 mcg/puff inhaler may help reduce or completely eliminate the need for systemic corticosteroids over time.

Aeronid 200 mcg/puff inhaler is not intended for the relief of acute bronchospasm or sudden asthma attacks and should not be used as a rescue medication.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

• Respiratory corticosteroids

• Nasal Decongestants & Other Nasal Preparations

Pharmacology

Aeronid 200 mcg/puff inhaler contains a corticosteroid with potent glucocorticoid activity and weak mineralocorticoid activity. Corticosteroids exert strong anti-inflammatory effects by inhibiting multiple inflammatory cell types, including mast cells, eosinophils, neutrophils, macrophages, and lymphocytes.

They also suppress the release of key inflammatory mediators such as histamine, leukotrienes, eicosanoids, and cytokines. These actions reduce airway inflammation, decrease bronchial hyper-responsiveness, and improve lung function, thereby contributing to effective long-term asthma control.

Dosage and Administration

Aeronid 200 mcg/puff inhaler is administered via oral inhalation in patients aged 6 years and older. Individual response and onset of symptom relief may vary. Improvement in asthma control may be observed within 24 hours, although maximum benefit may take 1–2 weeks or longer.

Adults

• Using bronchodilators alone

  • Starting dose: 200–400 mcg twice daily

  • Maximum dose: 400 mcg twice daily

• Using inhaled corticosteroids

  • Starting dose: 200–400 mcg twice daily

  • Maximum dose: 800 mcg twice daily

• Using oral corticosteroids

  • Starting dose: 400–800 mcg twice daily

  • Maximum dose: 800 mcg twice daily

Children (6 years and older)

• Using bronchodilators alone

  • Starting dose: 200 mcg twice daily

  • Maximum dose: 400 mcg twice daily

• Using inhaled corticosteroids

  • Starting dose: 200–400 mcg twice daily

  • Maximum dose: 400 mcg twice daily

• Using oral corticosteroids

  • Maximum recommended dose: 400 mcg twice daily

Once-daily dosing (200–400 mcg) may be considered in well-controlled mild to moderate asthma. If symptom control is inadequate, the total daily dose should be increased or divided.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Contraindications

• Primary treatment of status asthmaticus or acute asthma attacks

• Known hypersensitivity to Aeronid 200 mcg/puff or any of its components

Side Effects

Commonly reported adverse reactions include:

• General: Headache, fever, fatigue, flu-like symptoms

• Respiratory: Pharyngitis, sinusitis, rhinitis, cough, voice changes

• Gastrointestinal: Oral candidiasis, nausea, abdominal pain, vomiting

• Musculoskeletal: Myalgia, arthralgia, fractures

• Metabolic: Weight gain

• Neurological: Migraine, syncope

• Skin: Ecchymosis

• Psychiatric: Insomnia

• Special senses: Taste disturbance

Precautions and Warnings

During withdrawal from oral corticosteroids, patients should be carefully monitored for asthma instability and adrenal insufficiency. Aeronid 200 mcg/puff inhaler should be used at the lowest effective dose to minimize suppression of the hypothalamic-pituitary-adrenal (HPA) axis.

Patients may require temporary systemic corticosteroids during periods of stress or severe asthma exacerbations.

Storage Conditions

Store below 30°C, protected from light and moisture. Keep out of the reach of children.

Use in Special Populations

Paediatric studies show no clinically significant differences in the type or severity of adverse events between children and adults.